CUBIST PHARMACEUTICALS

cubist-pharmaceuticals-logo

Cubist Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides in the United States. It began promoting MERREM I.V. (meropenem for injection) in the U.S. in July 2008. MERREM is an established spectrum antibiotic... developed by AstraZeneca. The Cubist product pipeline includes ecallantide, a recombinant human protein in Phase 2 clinical trials; CONSERV-1 and CONSERV-2 for the reduction of blood loss during cardiac surgery; and two Phase 1 programs that address unmet medical needs, one in CDAD (Clostridium difficile-associated diarrhea) and the other in multi-drug resistant (MDR) Gram-negative infections. In addition, the company, in collaboration with Alnylam Pharmaceuticals, Inc., has a pre-IND and a Phase 2 program underway in novel treatments for respiratory syncytial virus infections using Alnylam's RNA-interference technology. Cubist was founded in 1992 and is headquartered in Lexington, Massachusetts.

#SimilarOrganizations #People #Financial #Website #More

CUBIST PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Medical

Founded:
1992-01-01

Address:
Lexington, Massachusetts, United States

Country:
United States

Website Url:
http://www.cubist.com

Total Employee:
5001+

Status:
Closed

Contact:
7812401261

Technology used in webpage:
SPF Microsoft Exchange Online Microsoft Azure DNS AWS Global Accelerator Rackspace Cisco Ironport Cloud Pubmatic Internap ATT DNS Rackspace Cloud Servers


Similar Organizations

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.


Current Advisors List

martin-rosenberg_image

Martin Rosenberg Board of Directors @ Cubist Pharmaceuticals
Board_member

kenneth-m-bate_image

Kenneth M. Bate Chairman of the Board @ Cubist Pharmaceuticals
Board_member

Current Employees Featured

paul-schimmel_image

Paul Schimmel
Paul Schimmel Founder @ Cubist Pharmaceuticals
Founder

debbie-durso-bumpus_image

Debbie Durso-Bumpus
Debbie Durso-Bumpus Senior Director &Talent Management @ Cubist Pharmaceuticals
Senior Director &Talent Management

Founder


john-clarke_image

John Clarke

paul-schimmel_image

Paul Schimmel

Stock Details


Company's stock symbol is NASDAQ:CBST

Acquisitions List

Date Company Article Price
2013-07-30 Trius Therapeutics Trius Therapeutics acquired by Cubist Pharmaceuticals 704 M USD
2013-07-30 Optimer Pharmaceuticals Optimer Pharmaceuticals acquired by Cubist Pharmaceuticals 535 M USD
2011-12-12 Adolor Adolor acquired by Cubist Pharmaceuticals N/A
2009-12-14 Calixa Therapeutics Calixa Therapeutics acquired by Cubist Pharmaceuticals N/A
2007-12-24 Illumigen Biosciences Illumigen Biosciences acquired by Cubist Pharmaceuticals N/A

Official Site Inspections

http://www.cubist.com

  • Host name: 155.91.16.177
  • IP address: 155.91.16.177
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Cubist Pharmaceuticals" on Search Engine